102
Participants
Start Date
November 29, 2017
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Onfekafusp alfa
Patients will receive a fixed dose of L19TNF in combination with a fixed dose of doxorubicin.
Doxorubicin
Patients will receive a fixed dose doxorubicin, administered as a 15 ± 5 minutes i.v. infusion.
NOT_YET_RECRUITING
AOU San Luigi Gonzaga, Orbassano
RECRUITING
Helios Klinikum Bad Saarow, Bad Saarow
RECRUITING
Fundación Jiménez Díaz, Madrid
RECRUITING
Universitaetsklinikum Muenster, Münster
RECRUITING
Uniklinik Köln, Cologne
RECRUITING
Universitätsklinikum Frankfurt, Frankfurt
RECRUITING
Institut Bergonié, Bordeaux
RECRUITING
Centre Georges François Leclerc, Dijon
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
Centre Antoine Lacassagne, Nice
NOT_YET_RECRUITING
Institut Claudius Regaud, Toulouse
NOT_YET_RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Charité- Universitätsmedizin Berlin, Berlin
NOT_YET_RECRUITING
Universitätsklinikum Düsseldorf, Düsseldorf
RECRUITING
Universitätsklinik Hamburg-Eppendorf, Hamburg
RECRUITING
Universitätsmedizin der J.-G. Universität Mainz, Mainz
RECRUITING
Klinik rechts der Isar, München
RECRUITING
IRCCS Fondazione del Piemonte per l'Oncologia Istituto per la Ricerca e la Cura del Cancro di Candiolo, Candiolo
RECRUITING
Bologna University, Chemotherapy Unit, IRCCS Istituto Ortopedico Rizzoli, Department of DIMES, Bologna
NOT_YET_RECRUITING
Szpital Pomorski Im. PCK, Gdynia
RECRUITING
Hospital Universitario Virgen de la Arrixaca, El Palmar
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
RECRUITING
Hospital Universitario Virgen de las Nieves, Granada
RECRUITING
Hospital General Universitario Gregorio Marañón, Madrid
RECRUITING
Hospital Miguel Servet, Zaragoza
RECRUITING
Heidelberg University Hospital, Heidelberg
NOT_YET_RECRUITING
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
RECRUITING
Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie Warszawa, Warsaw
Philogen S.p.A.
INDUSTRY